Differential transmission of human immunodeficiency virus type I by distinct subsets of effector dendritic cells

被引:117
作者
Sanders, RW
de Jong, EC
Baldwin, CE
Schuitemaker, JHN
Kapsenberg, ML
Berkhout, B
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Human Retrovirol, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands
关键词
D O I
10.1128/JVI.76.15.7812-7821.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Dendritic cells (DC) support human immunodeficiency virus type 1 (HIV-1) transmission by capture of the virus particle in the mucosa and subsequent transport to the draining lymph node, where HIV-1 is presented to CD4(+) Th cells. Virus transmission involves a high-affinity interaction between the DC-specific surface molecule DC-SIGN and the viral envelope glycoprotein gp120 and subsequent internalization of the virus, which remains infectious. The mechanism of viral transmission from DC to T cells is currently unknown. Sentinel immature DC (iDC) develop into Th1-promoting effector DC1 or Th2-promoting DC2, depending on the activation signals. We studied the ability of these effector DC subsets to support HIV-1 transmission in vitro. Compared with iDC, virus transmission is greatly upregulated for the DC1 subset, whereas DC2 cells are inactive. Increased transmission by DC1 correlates with increased expression of ICAM-1, and blocking studies confirm that ICAM-1 expression on DC is important for HIV transmission. The ICAM-1-LFA-1 interaction is known to be important for immunological cross talk between DC and T cells, and our results indicate that this cell-cell contact is exploited by HIV-1 for efficient transmission.
引用
收藏
页码:7812 / 7821
页数:10
相关论文
共 50 条
[1]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[2]   Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways [J].
Blauvelt, A ;
Asada, H ;
Saville, MW ;
KlausKovtun, V ;
Altman, DJ ;
Yarchoan, R ;
Katz, SI .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (08) :2043-2053
[3]   SUSCEPTIBILITY OF DENDRITIC CELLS TO HIV-1 INFECTION IN-VITRO [J].
CAMERON, PU ;
LOWE, MG ;
CROWE, SM ;
ODOHERTY, U ;
POPE, M ;
GEZELTER, S ;
STEINMAN, RM .
JOURNAL OF LEUKOCYTE BIOLOGY, 1994, 56 (03) :257-265
[4]   DENDRITIC CELLS EXPOSED TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSMIT A VIGOROUS CYTOPATHIC INFECTION TO CD4+ T-CELLS [J].
CAMERON, PU ;
FREUDENTHAL, PS ;
BARKER, JM ;
GEZELTER, S ;
INABA, K ;
STEINMAN, RM .
SCIENCE, 1992, 257 (5068) :383-386
[5]   The susceptibility to X4 and R5 human immunodeficiency virus-1 strains of dendritic cells derived in vitro from CD34+ hematopoietic progenitor cells is primarily determined by their maturation stage [J].
Canque, B ;
Bakri, Y ;
Camus, S ;
Yagello, M ;
Benjouad, A ;
Gluckman, JC .
BLOOD, 1999, 93 (11) :3866-3875
[6]   Maturation, activation, and protection of dendritic cells induced by double-stranded RNA [J].
Cella, M ;
Salio, M ;
Sakakibara, Y ;
Langen, H ;
Julkunen, I ;
Lanzavecchia, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (05) :821-829
[7]   A hairpin structure in the R region of the human immunodeficiency virus type 1 RNA genome is instrumental in polyadenylation site selection [J].
Das, AT ;
Klaver, B ;
Berkhout, B .
JOURNAL OF VIROLOGY, 1999, 73 (01) :81-91
[8]   Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse Th cell-polarizing signals [J].
de Jong, EC ;
Vieira, PL ;
Kalinski, P ;
Schuitemaker, JHN ;
Tanaka, Y ;
Wierenga, EA ;
Yazdanbakhsh, M ;
Kapsenberg, ML .
JOURNAL OF IMMUNOLOGY, 2002, 168 (04) :1704-1709
[9]   HIV-1 membrane fusion: Targets of opportunity [J].
Doms, RW ;
Moore, JP .
JOURNAL OF CELL BIOLOGY, 2000, 151 (02) :F9-F13
[10]   CD4 T cell cytokine differentiation: The B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1 [J].
Flynn, S ;
Toellner, KM ;
Raykundalia, C ;
Goodall, M ;
Lane, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (02) :297-304